GAVI has a board for each of its five entities. As a public-private partnership, the core of GAVI’s strategic guidance and direction is vested with two independent Boards, with unique but complementary roles. The Alliance also relies upon two independent boards to oversee the financial affairs of the International Finance Facility for Immunisation (IFFIm) and the pledging of IFFIm proceeds for GAVI programmes (The GAVI Fund Affiliate).

GAVI AllianceGAVI FundGAVI FoundationThe GAVI Fund AffiliateIFFIm

GAVI Alliance

The GAVI Alliance Board sets the programmatic policies for the Alliance, as well as monitors and oversees all programme areas. With membership drawn from a diverse range of partners, the Board provides a forum for balanced strategic decision making and partner collaboration.

The GAVI Alliance Board does not have bylaws as it is not a legal entity.  Its procedures are captured in its Guiding Principles.

Expand All | Contract All


The Board:

  • shapes the strategic vision and direction for the Alliance;
  • provides the highest-level policy decisions, ensuring alignment in Alliance partner activities;
  • reviews, approves and provides guidance on the 2006-2010 Alliance Strategic Plan, as well as corresponding work plans;
  • considers the recommendations of the Independent Review Committee and approves support for country immunisation programmes;
  • notes and monitors the commitments of Partners to undertake certain strategies and activities;
  • approves budgets of the Secretariat and any task force that might be established by the Board;
  • contributes, through its members, to fundraising and advocacy activities;
  • nominates the Executive Secretary and submits its name to the host organisation for appointment;
  • resolves issues among partners.

Core responsibilities are as follows:

  • As a member of the GAVI Alliance Board, to make an active and effective contribution to the Board’s collective performance of its functions as the governing body of the Alliance (see above), including regular attendance at meetings.
  • As a partner/constituency representative on the Board, to provide the highest level of representation, including:
    • maintaining close liaison between GAVI and the partner/constituency, including mutual exchange of ideas, issues and concerns;
    • fostering, and as appropriate strengthening, partner/constituency participation in activities designed to secure the strategic objectives of the Alliance.

NB. Decisions of the GAVI Board cannot override the authority of the governing boards of each individual member organisation.


The Board meets in principle twice a year, with teleconferences held as needed. The meeting agendas are prepared by the Executive Secretary in consultation with the Working Group and the Chairperson. The Executive Secretary is the Secretary of the Board.

Attendance of meetings by Board members is limited to their designated representatives, without the possibility of their replacement by alternates in the case of absence. Observers may be invited to contribute to Board meeting discussions in an ex-officio capacity, upon invitation from the Chairperson. While they may be invited to participate, observers will not be allowed to vote in Board deliberations.

The Board normally takes its decisions by consensus. Nevertheless should a vote be required each member will have one vote only. The decisions taken by the Board will not be considered as binding upon the organisations and will not override their respective governing bodies.


Following is the full list of 13 rotating members of the GAVI Board, showing the constituencies, respective terms of office, and the individual representing the institution.

Term of Office *
Represented by

Developing country government
Jan '07 - Dec '09
Dr Tedros Ghebreyesus, Minister of Health
Jan '07 - Dec '09
Dr Tatul Hakobyan, Deputy Minister of Health
Viet Nam
Jun '08 – Jun '11
Dr Trinh Quan Huan, Vice Minister of Health
Jun '08 – Jun '11
Dr Abdulkarim Yehia Rasae, Minister of Health
Vacant seat
Jun '08 - Jun '11
to be determined

Industralised country governments
United States
Jul '06 - Jun '09
Dr Kent R Hill, Assistant Administrator of the Bureau for Global Health, U.S. Agency for International Development (USAID)
United Kingdom
Jan '07 - Dec '08
Mr Gavin McGillivray, Head, Global Funds & Development, Finance Institutions Department, Department for International Development (DFID)
Jan '08 - Dec '09
Prof. Alberto Mantovani, School of Medicine, University of Milan & Scientific Director, Istituto Clinico Humanitas
Jan '07 - Dec '08
Dr Gustavo Gonzalez Canali, Special Health Adviser, Department for Development Policies (DPDEV), Ministry of Foreign Affaires
Jan '07 - Dec '08
Mrs Yoka Brandt, Deputy Director General for International Cooperation at the Ministry of Foreign Affairs

Research and technical health institutes
International Vaccine Institute
Jan '07 - Dec '09
Dr John Clemens, Director-General

Industrialised country vaccine industry
GlaxoSmithKline Biologicals
Jun '08 - May '11
Mr Jean Stéphenne, President and General Manager

Developing country vaccine industry
Serum Institute of India
Mar '08 - Feb '11
Dr Suresh Jadhav, Executive Director

Civil society organisation
Jul '08 - Jun '11
Dr Faruque Ahmed, Director

*At its July 2003 meeting the Board approved the extension of rotating Board member terms from two to three years, in order to allow rotating members to fully build their constituencies and contribute to the GAVI Board. All rotating members whose terms started later than June 2003 will serve for three years.

Following is the list of the 4 renewable members of the GAVI Board:

AgencyRepresented by

The World Health Organization (WHO)Dr Margaret Chan, Director-General (Chair)
Ms Daisy Mafubelu, Assistant Director-General, Family and Community Health

The United Nations Children’s Fund (UNICEF)Mr Saad Houry, Deputy Executive Director

The World Bank GroupMr Robert B. Zoellick (ex-officio member), President of the World Bank Group
Ms Joy Phumaphi, Vice President and Network Head, Human Development

The Bill & Melinda Gates FoundationDr Jaime Sepulveda, Director, Integrated Health Solutions Development

Procedures for new members

Criteria for selection of members

Consideration of eligible nominees is based on both organisational and individual factors:

  • 1. the current or potential importance of the partner institution to GAVI’s mission;
  • 2. the availability and commitment, both personal and institutional, to GAVI activities, including keeping the partner/constituency involved;
  • 3. expertise and experience that will contribute to GAVI Board discussions;
  • 4. technical, geographic and gender diversity in the composition of the Board;

In order to ensure an appropriate balance of expertise and/or technical, geographic and gender diversity on the Board, specific criteria may be applied to individual appointments. The notice inviting nominations will state any specific, as well as general, selection criteria.

Selection procedures for members
At present the GAVI Board has four renewable members – WHO, UNICEF, The World Bank, and the Bill & Melinda Gates Foundation – and thirteen rotating members whose terms, lasting for a three-year period, are non-renewable. This composition is subject to periodic review.

Procedures for renewable members:
Where renewable members wish to change their representative, they will provide a new nomination, supported by curriculum vitae, to the Board Chair who will determine the nomination on the basis of consultation.

Procedures for rotating members:
Rotation among non-renewable members will usually entail a change in organisation as well as individual representation. It is the responsibility of the non-renewable Board member whose term is coming to an end to undertake a timely and transparent exercise within the constituency to produce nomination(s) for a successor to the Board. Depending on timing, the GAVI Partners’ meeting may provide a forum for constituency consideration of forthcoming Board vacancies.  The GAVI Executive Secretary provides support, including details of general and any specific selection criteria. The Executive Secretary may, on request of the Board member, jointly issue the invitation.  On behalf of the constituency, the Board member will advise the Chair of the GAVI Alliance Board of the resulting nomination(s) at the end of the constituency exercise.

All nominations will be subject to a Board consultation process, led by the Chair. After consultation, the Chair will determine the selection, taking into account both the proposed organisation and the proposed individual. In cases of concern about the suitability of nominations received, the Chair will ask the constituency to come forward with an alternative candidate whose consideration will follow the same process.

Non-renewable Board members hold their seats until their successors are elected by the Board. Since demands vary from constituency to constituency, the outgoing Board member takes responsibility for a seamless handover to his or her successor. If at all possible, both should attend the Board meeting at the point of handover to ensure continuity.

Alliance Executive Committee

The GAVI Alliance Executive Committee was created in 2003 to enhance the strategic decision-making abilities of the Board. The Executive Committee oversees policy development and implementation, ensuring that key issues are properly reviewed prior to Board discussion. The Executive Committee has also been given the mandate to make critical, time-sensitive decisions that allow the Alliance to function between Board meetings.

AgencyRepresented by

Bill & Melinda Gates FoundationDr Jaime Sepulveda

UNICEFMr Saad Houry

The World Bank GroupMs Joy Phumaphi

WHODr Margaret Chan
Ms Daisy Mafubelu

GlaxoSmithKline BiologicalsMr Jean Stéphenne

USADr Kent R Hill

Serum Institute of IndiaDr Suresh S Jadhav

Developing CountryVacant